Fundz

Antiva Biosciences reported raising $26.6 Million in an initial SEC Form D filing, from an offering of $53 Million

PRIVATEMay 05, 2023$26.6M of $53M raised

Amount Raised

$26.6 Million

$26.6 Million sold, per SEC Form D (first sale Apr 24, 2023)

Round Type

Venture

Redwood CityBiotechnologyScience And Engineering

Quick answer

Antiva Biosciences raised $26.6 Million in a funding round, dated April 24, 2023. Antiva Biosciences is based in Redwood City, California, United States.

How much did Antiva Biosciences raise?
Antiva Biosciences raised $26.6 Million in a funding round on April 24, 2023.
What does Antiva Biosciences do?
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection.
Where is Antiva Biosciences based and how big is it?
Antiva Biosciences is based in Redwood City, California, United States.
Who are the decision-makers at Antiva Biosciences?
Fundz holds 2 contacts at Antiva Biosciences, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as Antiva Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Upstream Bio raised $200M (Series B) on June 8, 2023.
  • GenEp raised $5M (Seed) on May 17, 2023.
  • Ray Therapeutics raised $14M on May 15, 2023.
  • Wheeler Bio raised $31M (Series A) on April 13, 2023.
  • Geneos Therapeutics raised $5M (Series A) on April 12, 2023.
  • Geneos Therapeutics raised $5M (Series A) on March 31, 2023.

Who to call at Antiva Biosciences, and when

A new round usually means Antiva Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Antiva Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Antiva Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Antiva Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Antiva Biosciences

Location

555 Twin Dolphin Drive, Suite 620

Redwood City, California, United States

About

Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. We aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV. Our lead programs are in clinical trials in high grade anal intraepithelial neoplasias (AIN 2,3) and high grade cervical intraepithelial neoplasias (CIN 2,3). The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antiva’s chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Antiva Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsGail M., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Antiva Biosciences's next move

See what Strategic adds

Antiva Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.